Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 62332-080

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 62332-080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Valsahctz 160 12 5mg

This is a description of a medication called "Valsartan and Hydrochlorothiazide Tablets, USP" containing 160 mg/12.5 mg. It comes in a bottle with 30 tablets and has a GTIN code of 0036232080304. There is also some additional text that is not legible.*

FDA Label Image

30's Bottle Pack (Valsahctz 160 25mg)

This text seems to be a medication label and provides information about a medication called "Valsartan and Hydrochlorothiazide". It mentions the strength of the medication, the dosage form (tablets), and that it can only be obtained with a prescription. The rest of the text appears to be garbled or incomplete due to errors, making it difficult to decipher any additional information.*

FDA Label Image

Valsahctz 320 12 5mg

FDA Label Image

30's Bottle Pack (Valsahctz 320 25mg)

FDA Label Image

Valsahctz 80 12 5mg

FDA Label Image

Figure 1 (Valsahctz Figur1)

This is a graph describing the probability of achieving systolic blood pressure below 140 mmHg at Week 8. It is not clear what the x-axis represents, but it ranges from 140 to 180 mmHg. The y-axis shows the probability percentage. The graph seems to compare the effect of two different medications, "Vasarian and hydrochlorothiazide tablets" and "Hydrochlorothiazide 25mg". However, there is not enough context to support this statement.*

FDA Label Image

Figure 2-3-4 (Valsahctz Figure2 3 4)

The text contains data on blood pressure achieved using Valsartan and Hydrochlorothiazide tablets at week 8. The graphs display probabilities of achieving diastolic and systolic blood pressure levels of <90 and <130 mmHg respectively. The tables show the baseline systolic and diastolic blood pressure for each treatment category.*

FDA Label Image

Structure (Valsahctz Hctz)

FDA Label Image

Structure (Valsahctz Valsa)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.